Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
4,963 total articles
Agios Pharmaceuticals Chief Legal Officer James William Burns sold 3,280 shares on April 2, 2026, and exercised options on 8,500 shares the same day. The company reported regulatory progress for mitapivat in sickle cell disease, prompting analyst target increases and continued Buy ratings from major firms.
Mid-America Apartment Communities Inc. EVP and CFO Aubrey Clay Holder sold 145 shares under a 10b5-1 plan on April 6, 2026, for $18,085. The filing also shows recent acquisitions and a tax-related disposal. The REIT trades near $124.82 with a market capitalization of about $14.97 billion, yields 4.9% in dividends and has paid dividends for 33 conse…
Oasis Investments II Master Fund Ltd. sold 5,417 shares of Stratus Properties Inc. (NASDAQ: STRS) on April 2, 2026, for $30.1148 per share, generating proceeds of $163,131. The transaction occurred while STRS traded close to its 52-week high of $32.93, after a 79% gain over the prior 12 months. InvestingPro analysis indicates the stock appears over…
Tsveta Milanova, Chief Commercial Officer of Agios Pharmaceuticals (NASDAQ: AGIO), sold 3,262 shares on April 2, 2026, for roughly $113,224 to meet tax obligations tied to vested performance share units. On the same date she exercised options to acquire 8,500 shares at a $0 exercise price after those units vested upon achievement of a regulatory mi…
Shoe Carnival Inc. Executive Vice President and Chief Financial Officer W. Kerry Jackson purchased 31,000 shares of the company on April 2, 2026, spending $500,029 in a series of trades priced between $16.07 and $16.20. The stock is trading at $15.93, close to its 52-week low of $15.04. Jackson now directly holds 215,529 shares. Separately, Shoe Ca…
Agios Pharmaceuticals CFO Cecilia Jones sold 3,141 shares on April 2, 2026, for $34.71 per share, netting $109,024 to satisfy tax withholding tied to vested performance share units. The sale was carried out under a pre-established Rule 10b5-1 trading plan; Jones also exercised options for 8,500 shares that vested as part of the same award. The stoc…
Hershey Trust Co., acting as trustee in trust for the Milton Hershey School, sold 8,390 shares of Hershey Co. (HSY) common stock on April 2, 2026, in multiple transactions that generated roughly $2.04 million in proceeds. The trades were reported on a Form 4 filing and occurred at prices between $200.97 and $206.217 per share. The disposal alters t…
Privia Health Group CFO David Mountcastle sold 5,566 shares on April 2, 2026, in a transaction tied to tax withholding from vested restricted stock units, netting about $116,051. Following the sale Mountcastle holds 214,847 shares directly and 8,695 indirectly through a spouse. Separately, several analysts raised or affirmed price targets and ratin…
Horizon Kinetics Asset Management LLC, a roughly 10% holder of Texas Pacific Land Corp (NYSE: TPL), reported acquiring a single share on April 2, 2026, at $443.26. The firm now beneficially owns 3,461,344 shares. The purchase comes as TPL trades near $446, with a market capitalization of $30.73 billion, a strong year-to-date gain, mixed quarterly r…
Murray Stahl, President and Co-Portfolio Manager of RENN Fund (RCG), reported buying 1,134 shares of common stock on April 2, 2026, spending a total of $3,708 at $3.27 per share. The direct portion of the purchase increased Stahl's direct holdings to 159,968 shares. The acquisitions included multiple indirect purchases through affiliated entities a…
GlobalFoundries Chief Legal Officer Azar Samak L sold 500 ordinary shares on April 2, 2026, at $42.96 per share for a total of $21,480. The sale was executed under a Rule 10b5-1 trading plan adopted before the majority shareholder offering and was permitted under an existing lock-up agreement that expires May 10, 2026. The company is also pursuing …
A director of Huron Consulting Group Inc. executed an automated sale of 126 shares on April 2, 2026, under a pre-arranged Rule 10b5-1 plan, while the company reported fourth-quarter results that topped analyst estimates. Despite the quarter's outperformance, a broad 2026 guidance range and questions about artificial intelligence's potential impact …
Debra Zumwalt, a director at Huron Consulting Group Inc (HURN), sold 170 shares on April 2, 2026, under a Rule 10b5-1 plan. The transaction totaled $21,578. The company recently reported better-than-expected fourth-quarter results, but management left a wide guidance range for 2026 amid questions about how artificial intelligence may affect the bus…
Chewy Inc. general counsel and corporate secretary Hu Da-Wai sold 8,149 shares of Class A common stock on April 1, 2026, at $26.91 per share, a transaction worth $219,289. The filing shows a mosaic of restricted stock units and performance-based awards remaining in Hu’s holdings. Meanwhile, analysts have adjusted price targets and recommendations f…
Japan Post Holdings Co., Ltd. sold 20,100 shares of Aflac Inc. (NYSE: AFL) on April 2, 2026, in two transactions that together totaled roughly $2.2 million, according to a Form 4 filing. The insurer's shares trade near $110 and carry a market value of about $56.68 billion. Recent company results showed a revenue beat but an earnings shortfall, and …
Jorey Chernett, a 10% owner of AirSculpt Technologies, purchased 90,000 shares on April 3, 2026, at a weighted average price of $2.82 for a total outlay of $253,800, according to a Form 4 filing. The buy occurred as the stock has risen sharply year-to-date and after the company reported fourth-quarter 2025 results that modestly exceeded consensus e…
Chief Commercial Officer Bruno Thomas purchased 10,000 shares of Culp Inc common stock on April 2, 2026, spending $27,650 on shares priced between $2.75 and $2.78. The transaction leaves Thomas with 90,000 shares directly held. The trade comes as the stock changes hands at $2.71, roughly 1% above its 52-week low of $2.70, and after the company repo…
Spyre Therapeutics' CFO Scott L. Burrows sold 7,500 shares on April 1, 2026, realizing roughly $370,076, and exercised options to acquire 7,500 shares at $14.50 the same day. The stock trades near its 52-week high amid accelerated clinical timelines and several analyst target increases, while an InvestingPro analysis flags the shares as overvalued …
Fold Holdings Chief Executive William Brian Poppic Reeves sold 5,710 shares of the company's common stock on April 2, 2026, in a transaction disclosed on a Form 4 filing. The sale, executed at $1.222 per share for a total of $6,977, was made to satisfy tax withholding related to the vesting and settlement of restricted stock units and was not discr…
Spyre Therapeutics Chief Executive Officer Turtle Cameron sold 15,000 shares of common stock on April 1, 2026, for roughly $739,912, according to a Form 4 filing. The transactions took place under a Rule 10b5-1 trading plan adopted June 20, 2025. The sales occurred as Spyre's share price sits near its 52-week high amid accelerated clinical timeline…
Spyre Therapeutics NASDAQ:SYRE Chief Medical Officer Sloan Sheldon sold 7,958 shares on April 1, 2026, at $50.00 per share, generating $397,900, and on the same day exercised options to buy 7,958 shares at $21.66 per share for $172,370. Following the transactions, Sheldon holds no direct shares. The trades were carried out under a Rule 10b5-1 plan …
Fold Holdings Chief Technology Officer Thomas J. Dickman sold six shares of common stock on April 2, 2026, for a total of $7 to satisfy tax withholding obligations after acquiring 17 shares on April 1. The insider activity comes as Fold shares trade near their 52-week low and the company reports a revenue miss for fiscal 2025 Q4 alongside declining…
Fold Holdings CFO Wolfe Repass sold 1,326 shares on April 2, 2026, to satisfy tax-withholding obligations tied to the vesting and settlement of restricted stock units. The transaction, described as non-discretionary, coincides with a period in which Fold's shares have declined sharply and the company reported a revenue miss for fiscal 2025 Q4, prom…
Brian M. Venturo, Chief Strategy Officer of CoreWeave, Inc. (NASDAQ: CRWV), sold $111.6 million worth of Class A common stock across transactions on April 1 and April 2, 2026, carried out under a pre-established 10b5-1 trading arrangement. The disposals took place at per-share prices between $77.4269 and $81.2986, and coincided with conversions of …
Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, Inc. (NASDAQ: NTRA), sold 8,400 shares of common stock on April 1, 2026 under a Rule 10b5-1 trading plan. The trades amounted to $1.7 million at weighted average prices between $200.7868 and $205.0026 per share. The disclosures come as Natera shares trade at $207.98, up 55% over the past yea…
